Vaccine makers Pfizer and BioNTech said they will complete their submission for emergency use authorization of their Covid-19 vaccine for children under the age of 5 this week after a study of a third dose found it improves the efficacy of the vaccine.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,